Castle Biosciences Inc To Acquire Cernostics Inc Call Transcript
Hello, and welcome to the Castle Biosciences Acquisition Webcast Call. My name is Lauren, and I will be coordinating your call today. (Operator Instructions)
I will now hand you over to your host, Derek Maetzold, CEO of Castle Biosciences to begin. Derek, please go ahead.
Thank you, Lauren. Good morning, everybody. On the call with me this morning is Frank Stokes, Castle Biosciences Chief Financial Officer; and Mike Hoerres, Cernostics' Chief Executive Officer; and this is Derek Maetzold, the President and CEO of Castle Biosciences. We appreciate you joining our call this morning for what we find as a very exciting announcement.
We are pleased this morning to announce the signing of a definitive agreement to acquire Cernostics. Cernostics is a Pittsburgh, Pennsylvania, diagnostic laboratory that works in the field of spatial biology and biologically aware AI and machine learning. Their lead product is the TissueCypher test for use in patients diagnosed with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |